FTXH vs. FBT
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and FBT (First Trust Amex Biotechnology Index) are both Health & Biotech Equities funds from First Trust - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while FBT tracks the NYSE Arca Biotechnology Index. Both are passively managed. Over the past 5 years, FTXH returned 8.45%/yr vs 6.27%/yr for FBT. A 0.66 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.57%/yr for FBT.
Performance
FTXH vs. FBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 10.44% return, which is significantly lower than FBT's 11.66% return.
FTXH
- 1D
- 1.37%
- 1M
- 4.15%
- YTD
- 10.44%
- 6M
- 9.18%
- 1Y
- 44.59%
- 3Y*
- 12.98%
- 5Y*
- 8.45%
- 10Y*
- —
FBT
- 1D
- 0.35%
- 1M
- 8.29%
- YTD
- 11.66%
- 6M
- 7.46%
- 1Y
- 45.08%
- 3Y*
- 13.91%
- 5Y*
- 6.27%
- 10Y*
- 10.49%
FTXH vs. FBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 10.44% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
FBT First Trust Amex Biotechnology Index | 11.66% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
Correlation
The correlation between FTXH and FBT is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.81 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.80 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.74 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016 | 0.66 |
The correlation between FTXH and FBT shifts across timeframes, from 0.66 (all time) to 0.81 (1 year), reflecting how their relationship changes across market environments.
FTXH vs. FBT - Sectors Allocation Comparison
Sectors
FTXH
FBT
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
FBT
Basic Materials
FTXH
-
FBT
-
Communication Services
FTXH
-
FBT
-
Consumer Cyclical
FTXH
-
FBT
-
Consumer Defensive
FTXH
-
FBT
-
Energy
FTXH
-
FBT
-
Financial Services
FTXH
-
FBT
-
Industrials
FTXH
-
FBT
-
Real Estate
FTXH
-
FBT
-
Technology
FTXH
-
FBT
-
Utilities
FTXH
-
FBT
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. FBT — Risk / Return Rank
FTXH
FBT
FTXH vs. FBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTXH | FBT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.45 | ||
| Sortino ratioReturn per unit of downside risk | +0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.37 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 6.00 | 3.18 | +2.82 |
| Martin ratioReturn relative to average drawdown | 17.65 | 9.39 | +8.26 |
Loading charts...
Drawdowns
FTXH vs. FBT - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum FBT drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for FTXH and FBT.
Loading charts...
Drawdown Indicators
| FTXH | FBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -40.51% | +8.40% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -14.26% | +6.79% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -20.05% | +0.54% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -28.98% | +9.47% |
Max Drawdown (10Y)Largest decline over 10 years | — | -32.37% | — |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -5.81% | -11.14% | +5.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.53% | 4.81% | -2.28% |
Volatility
FTXH vs. FBT - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.42%, while First Trust Amex Biotechnology Index (FBT) has a volatility of 6.54%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | FBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.42% | 6.54% | -1.12% |
Volatility (6M)Calculated over the trailing 6-month period | 12.04% | 16.15% | -4.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.18% | 21.02% | -3.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.37% | 21.88% | -5.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.42% | 23.83% | -5.41% |
FTXH vs. FBT - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than FBT's 0.57% expense ratio.
Dividends
FTXH vs. FBT - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.16%, while FBT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.16% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
Frequently Asked Questions
FTXH and FBT have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBT has higher volatility (6.54%) compared to FTXH (5.42%). In terms of maximum drawdown, FTXH dropped -32.11% vs FBT's -40.51%.
On 5-year performance, FTXH leads with 8.45% vs 6.27% for FBT. On fees, FBT is cheaper at 0.57% per year. On volatility, FTXH has been the lower-risk option at 5.42%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.45% return vs 6.27%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FBT is cheaper with a 0.57% expense ratio, compared with 0.60% for FTXH.
FTXH has the higher dividend yield at 1.16%, compared with 0.00% for FBT.
FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while FBT tracks NYSE Arca Biotechnology Index. Their fees differ too: 0.60% for FTXH and 0.57% for FBT.
FTXH currently has the higher Sharpe Ratio (2.61 vs 2.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and FBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer